Javitt Daniel C.

10% OwnerNRX Pharmaceuticals, Inc. (NRXP) · full profile →Form 4 · filed Jun 7, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$304K
Net Open-Market Flow
-$304K
Transactions
3
3 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jun 7, 2022Sell(S)86K$0.65$56K12.7M
Jun 6, 2022Sell(S)116K$0.67$77K12.7M
Jun 3, 2022Sell(S)244K$0.70$171K12.9M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0000880984-22-000007) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.